On the road to Liberty

The WHO is trying to fight the huge international trade in counterfeits but faces opposition from India and others, driven by a strange coalition ranging from the far Left to business organisations: this author blows away some of the straw men these people have built up. Barun Mitra says robust trademark protection will give Indian companies a stake in quality and give Indian, and worldwide, patients the guarantees that they need. My article titled India: Urgent steps are needed to ensure quality medicines was published in The Pioneer on March 31, 2009 Indian pharmaceutical companies are supplying sub-standard drugs in Maharashtra. While the home-grown nature of the problem at least means that a solution lies in our own hands, the Government is sending a worrying signal by blocking the World Health Organisation's efforts to improve drug quality around the world. Maharashtra's Medical, Education and Drugs Secretary Bhushan Gagrani said that 547 samples of Indian-produced sub-st...

India's compliance with TRIPS will not hinder the poor's access to essential medicines; rather, it is the government's hold on the healthcare sector that makes equitable healthcare impossible. My article titled Misdiagnosing the diseases of the poor was published in The Indian Express on January 28 2005. The present debate over the Indian patent law, despite the passion, is underscored by the desire to score political points. Consequently, most of the arguments have been disconnected from reality. India has been a proving ground for those who oppose patents on pharmaceutical products. We scrapped all product patents in 1972. As a result, India is now home to over 20,000 pharmaceutical companies producing copies of drugs developed óand patentedó elsewhere. However, access to medicines remains pooró suggesting that patents are not the key determinant of access that their opponents claim. In India, medicine represents between 10 and 15% of total health care costs. This will...

The present debate over the Indian patent law has done a disservice to the poor patients by shifting the focus away from the more sickness that afflicts the health care system in India. Its not patents but the government hold on the health care sector that is preventing the poor from gaining access to medicines. A version of this article titled "Patients, not Patents, need to be at heart of the health care debate" has appeared in The Indian Express , January 28, 2004 The present debate over the Indian patent law, despite the passion, is underscored by the desire to score political points. Consequently, most of the arguments have been disconnected from reality. India has been a proving ground for those who oppose patents on pharmaceutical products. We scrapped all product patents in 1972. As a result, India is now home to over 20,000 pharmaceutical companies producing copies of drugs developed and patented elsewhere. However, access to medicines remains poor suggesting that p...